S. Ivanković

7.5k total citations · 2 hit papers
105 papers, 5.7k citations indexed

About

S. Ivanković is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, S. Ivanković has authored 105 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in S. Ivanković's work include Carcinogens and Genotoxicity Assessment (11 papers), Nitric Oxide and Endothelin Effects (6 papers) and Amino Acid Enzymes and Metabolism (5 papers). S. Ivanković is often cited by papers focused on Carcinogens and Genotoxicity Assessment (11 papers), Nitric Oxide and Endothelin Effects (6 papers) and Amino Acid Enzymes and Metabolism (5 papers). S. Ivanković collaborates with scholars based in Germany, Austria and Switzerland. S. Ivanković's co-authors include H. Druckrey, R. Preußmann, D. Schmähl, H. D. Mennel, D. Schm�hl, Hans‐Jörg Schneider, M. M�ller, D. Steinhoff, W. Jens Zeller and H. Kruse and has published in prestigious journals such as Nature, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

S. Ivanković

102 papers receiving 5.1k citations

Hit Papers

[Organotropic carcinogenic effects of 65 various N-nitros... 1967 2026 1986 2006 1967 1967 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Ivanković Germany 34 2.0k 1.3k 778 722 560 105 5.7k
H. Druckrey Germany 39 2.3k 1.1× 1.4k 1.1× 753 1.0× 837 1.2× 636 1.1× 140 6.7k
Peter Magee United States 41 2.6k 1.3× 1.3k 1.0× 791 1.0× 698 1.0× 489 0.9× 134 5.6k
R. Preußmann Germany 45 2.9k 1.4× 1.8k 1.4× 1.7k 2.2× 1.4k 1.9× 663 1.2× 228 9.1k
Elizabeth K. Weisburger United States 38 1.8k 0.9× 1.8k 1.4× 707 0.9× 388 0.5× 583 1.0× 177 4.8k
Walter Troll United States 40 3.3k 1.6× 1.2k 1.0× 353 0.5× 233 0.3× 652 1.2× 132 6.4k
Eliezer Huberman United States 55 5.9k 2.9× 2.5k 2.0× 690 0.9× 504 0.7× 1.6k 2.8× 153 9.3k
Joseph P. Brown United States 44 2.7k 1.3× 669 0.5× 693 0.9× 219 0.3× 827 1.5× 116 6.4k
D. Schmähl Germany 25 935 0.5× 629 0.5× 399 0.5× 289 0.4× 666 1.2× 153 3.1k
Alan R. Buckpitt United States 38 1.5k 0.8× 936 0.7× 838 1.1× 603 0.8× 521 0.9× 128 4.6k
Richard H. Adamson United States 37 1.5k 0.8× 754 0.6× 275 0.4× 131 0.2× 803 1.4× 135 4.3k

Countries citing papers authored by S. Ivanković

Since Specialization
Citations

This map shows the geographic impact of S. Ivanković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ivanković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ivanković more than expected).

Fields of papers citing papers by S. Ivanković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Ivanković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ivanković. The network helps show where S. Ivanković may publish in the future.

Co-authorship network of co-authors of S. Ivanković

This figure shows the co-authorship network connecting the top 25 collaborators of S. Ivanković. A scholar is included among the top collaborators of S. Ivanković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Ivanković. S. Ivanković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Port, Rüdiger E., et al.. (1994). Influence of Tetrachlorodecaoxide (Ryoxon®) on the Development of Leukemia after Total-Body Gamma-Irradiation. Oncology. 51(6). 510–514. 3 indexed citations
2.
Ivanković, S., et al.. (1988). Regenerative Effects of Tetrachlorodecaoxide in BD IX Rats after Total-Body γ Irradiation. Radiation Research. 115(1). 115–115. 7 indexed citations
3.
Ivanković, S., et al.. (1987). Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (mesna): experimental results. Cancer Treatment Reviews. 14(3-4). 365–372. 8 indexed citations
4.
Zeller, W. Jens, S. Ivanković, M. Habs, & D Schmähl. (1982). EXPERIMENTAL CHEMICAL PRODUCTION OF BRAIN TUMORS*. Annals of the New York Academy of Sciences. 381(1). 250–263. 4 indexed citations
5.
Brune, H., R. Deutsch‐Wenzel, M. Habs, S. Ivanković, & D. Schm�hl. (1981). Investigation of the tumorigenic response to benzo(a)pyrene in aqueous caffeine solution applied orally to Sprague-Dawley rats. Journal of Cancer Research and Clinical Oncology. 102(2). 153–157. 40 indexed citations
6.
Ivanković, S., Gerhard Eisenbrand, & R. Preußmann. (1979). Lung carcinoma induction in BD rats after a single intratracheal instillation of an arsenic‐containing pesticide mixture formerly used in vineyards. International Journal of Cancer. 24(6). 786–788. 31 indexed citations
7.
Schmähl, D., M. Habs, & S. Ivanković. (1978). Carcinogenesis of N‐nitrosodiethylamine (DENA) in chickens and domestic cats. International Journal of Cancer. 22(5). 552–557. 17 indexed citations
8.
Ivanković, S., R. Port, & R. Preußmann. (1976). Unterschiedliche carcinogene Wirkungen von 1-Phenyl- und 1-(Pyridyl-3)-3,3-di�thyl-triazen an BD-Ratten nach Gabe einer Einzeldosis am 1., 10. oder 30. Lebenstag. Journal of Cancer Research and Clinical Oncology. 86(3). 307–313. 6 indexed citations
9.
Graw, Jochen, S. Ivanković, Henk van den Berg, & D Schmähl. (1975). [Teratogenic action of ethyl-nitrosourea in Göttingen miniature pigs (author's transl)].. PubMed. 25(10). 1606–8. 2 indexed citations
11.
Schmähl, D., et al.. (1974). [Cure of acute leukaemia L 5222 in rats by a single course of treatment with vincristin and cyclophosphamide, or 1,3-bis-(2-chloroethyl)-1-nitroso-urea (BCNU) and cyclophosphamide (author's transl)].. PubMed. 99(25). 1367–8. 1 indexed citations
12.
Ivanković, S., et al.. (1972). Erzeugung von Herztumoren durch chronische orale Gabe des Carcinogens 1-Pyridyl-3, 3-Diäthyl-Triazen an BD-Ratten. Journal of Cancer Research and Clinical Oncology. 77(3). 217–225. 8 indexed citations
13.
Druckrey, H., et al.. (1970). [Carcinogenic alkylating substances. IV. 1,3-propane sultone and 1,4-butane sultone].. PubMed. 75(1). 69–84. 6 indexed citations
14.
Druckrey, H., et al.. (1970). [Cancerogenic alkylating substances. 3. Alkyl-halogenides, -sulfates, -sulfonates and strained heterocyclic compounds].. PubMed. 74(3). 241–73. 78 indexed citations
15.
Druckrey, H., S. Ivanković, & R. Preußmann. (1966). Teratogenic and Carcinogenic Effects in the Offspring after Single Injection of Ethylnitrosourea to Pregnant Rats. Nature. 210(5043). 1378–1379. 228 indexed citations
16.
Druckrey, H., S. Ivanković, & R. Preußmann. (1965). Selektive Erzeugung maligner Tumoren im Gehirn und Rückenmark von Ratten durch N-Methyl-N-nitrosoharnstoff. Journal of Cancer Research and Clinical Oncology. 66(5). 389–408. 112 indexed citations
17.
Druckrey, H., et al.. (1964). [SELECTIVE INDUCTION OF BLADDER CANCER IN RATS BY DIBUTYL- AND N-BUTYL-N-BUTANOL(4)-NITROSAMINE].. PubMed. 66. 280–90. 125 indexed citations
18.
Druckrey, H., et al.. (1963). [QUANTITATIVE ANALYSIS OF THE CARCINOGENIC EFFECT OF DIETHYLNITROSAMINE].. PubMed. 13. 841–51. 54 indexed citations
19.
Seemayer, N.H., et al.. (1957). [Research on the effect of actinomycin C on the Yoshida sarcoma of rats].. PubMed. 62(2). 242–3. 1 indexed citations
20.
Ivanković, S., et al.. (1957). [Effect of actinomycin C on a transplantable lymphosarcoma of mice].. PubMed. 62(2). 239–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026